MetLife Investment Management’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $237K | Hold |
31,454
| – | – | ﹤0.01% | 2103 |
|
|
2025
Q1 | $238K | Sell |
31,454
-604
| -2% | -$4.57K | ﹤0.01% | 2109 |
|
|
2024
Q4 | $390K | Buy |
32,058
+2,217
| +7% | +$27K | ﹤0.01% | 1929 |
|
|
2024
Q3 | $500K | Buy |
29,841
+7,115
| +31% | +$119K | ﹤0.01% | 1784 |
|
|
2024
Q2 | $396K | Buy |
22,726
+9,389
| +70% | +$164K | ﹤0.01% | 1855 |
|
|
2024
Q1 | $227K | Hold |
13,337
| – | – | ﹤0.01% | 2127 |
|
|
2023
Q4 | $136K | Hold |
13,337
| – | – | ﹤0.01% | 2450 |
|
|
2023
Q3 | $121K | Hold |
13,337
| – | – | ﹤0.01% | 2484 |
|
|
2023
Q2 | $144K | Sell |
13,337
-3,088
| -19% | -$33.2K | ﹤0.01% | 2472 |
|
|
2023
Q1 | $168K | Hold |
16,425
| – | – | ﹤0.01% | 2324 |
|
|
2022
Q4 | $173K | Sell |
16,425
-3,464
| -17% | -$36.5K | ﹤0.01% | 2336 |
|
|
2022
Q3 | $255K | Buy |
19,889
+4,491
| +29% | +$57.6K | ﹤0.01% | 2130 |
|
|
2022
Q2 | $197K | Hold |
15,398
| – | – | ﹤0.01% | 2324 |
|
|
2022
Q1 | $161K | Buy |
15,398
+5,590
| +57% | +$58.5K | ﹤0.01% | 2479 |
|
|
2021
Q4 | $151K | Hold |
9,808
| – | – | ﹤0.01% | 2228 |
|
|
2021
Q3 | $221K | Buy |
9,808
+3,710
| +61% | +$83.7K | ﹤0.01% | 2025 |
|
|
2021
Q2 | $157K | Hold |
6,098
| – | – | ﹤0.01% | 2303 |
|
|
2021
Q1 | $254K | Buy |
+6,098
| New | +$254K | ﹤0.01% | 1919 |
|